• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Arterioscler Thromb Vasc Biol. Author manuscript; available in PMC Sep 1, 2010.
Published in final edited form as:
PMCID: PMC2757736
NIHMSID: NIHMS131282

Interferon-gamma induces prolyl hydroxylase (PHD)3 through a STAT1-dependent mechanism in human endothelial cells

Abstract

Objective

We previously reported that interferons (IFNs) regulate transcription of HIF-1α in human endothelial cells (ECs), linking immunity and hypoxia. Prolyl hydroxylases (PHDs) regulate expression of HIF-1α in response to hypoxia. We examined whether IFNs affect PHD expression and whether PHDs regulate the EC response to IFNs.

Methods and Results

Human cell cultures were treated with various cytokines and PHD expression was examined using qRT-PCR and immunoblotting. IFNγ and, to a lesser extent, IFNα significantly induced PHD3, but not PHD1 or 2, mRNA and protein expression selectively in ECs directly via a JAK/STAT1 pathway as demonstrated by pharmacological inhibition, siRNA knockdown and chromatin immunoprecipitation. Inhibition of PHD activity with dimethyloxallyl glycine or desferroxamine reduced IFNg-dependent responses in these same cells.

Conclusions

IFNγ induces PHD3 through a JAK/STAT1-dependent mechanism in human ECs. Induction is independent of HIF-1α and may contribute to expression of IFNγ-dependent genes.

Keywords: IFNγ signaling, endothelial cells, hypoxia, PHD3, HIF-1α

Hypoxia activates transcription of genes necessary for adaptation to low oxygen 1, 2. The best described response system utilizes hypoxia-inducible factors (HIFs) composed of the constitutively expressed subunit HIF-1β bound to labile subunits HIF-1α or HIF-2α forming HIF-1 or HIF-2, respectively 3. HIF expression is regulated by a family of prolyl hydroxylases, PHD1, PHD2 and PHD3, that sense oxygen tension through its binding to an associated iron atom 4, 5. When the PHD iron is occupied by O2, these enzymes catalyze a reaction in which one oxygen atom reacts with 2-oxoglutarate to form succinate and CO2 while the other is transferred to a proline residue in a protein substrate, such as HIF-1α to form a hydroxyproline side chain. Hydroxylation of proline in HIF-1α recruits the von Hippel-Lindau (pVHL) complex, targeting HIF-1α for ubiquitination and proteasomal degradation 68. Molecular oxygen is normally rate limiting and hypoxia causes HIF-1α protein stabilization and accumulation by inhibiting PHD-mediated proline hydroxylation. As its levels increase, HIF-1α enters the nucleus and dimerizes with HIF-1β to form active HIF-1, initiating transcription of genes that aid in adaptation to hypoxic conditions including enzymes that favor anaerobic glycolysis and factors that stimulate both angiogenesis and erythropoiesis 5, 9. PHD3 transcription is induced by HIF-1 under hypoxic conditions through a functional hypoxic response element (HRE) located in the first intron of PHD3 10. HIF-1-dependent induction of PHD3 most likely serves as a negative feedback mechanism during hypoxia, and may promote the rapid degradation of HIF-1α or HIF-2α upon reoxygenation 6, 11, 12.

Although most closely identified with the hypoxic response, PHDs may also regulate other molecular systems. PHD1 negatively regulates the NF-κB pathway by repressing the activity of the positive regulator, IKKβ through hydroxylation in an oxygen sensitive reaction 13. In rodents, PHD3 is required for normal neurological development through induction of neuron apoptosis 14, 15. Loss of PHD3 impairs development of sympathetic neurons and may lead to the formation of pheochromocytomas 16. PHD3 interacts with activating transcription factor-4 (ATF-4) and negatively regulates the stability of this stress-induced protein in an oxygen-dependent manner 17. Finally, PHD3 has been shown to induce subcellular aggregation of proteasomal components that are similar to aggresome-like structures 18. These protein aggregates may activate apoptosis in certain cell types in an oxygen-dependent manner that requires PHD3 hydroxylase activity. Inhibition of PHD3 activity by hypoxia or pharmacologic inhibitors, such as dimethyloxyallyl glycine (DMOG), prevents PHD3-induced protein aggregation and subsequent apoptosis.

The interaction of the immune system and elements of the HIF system have recently been observed in several cell types 19, 20. Cytokines that activate NF-κB may increase HIF-1α by driving increased transcription 21. We have recently reported that IFNα, a type I IFN, may also increase HIF-1α in human endothelial cells (ECs) by activating its transcription though a Janus activated kinase (JAK)/ signal transducer and activator of transcription (STAT) signaling pathway involving the transcription factor interferon-stimulated gene factor (ISGF)3 (a complex consisting of STAT1, STAT2 and interferon response factor (IRF)9), and that this mechanism may contribute to the anti-proliferative effects of this cytokine 22. While IFNα primarily mediates anti-viral effects, IFNγ, also known as type II IFN, primarily exerts immunomodulatory effects23. In ECs, IFNγ enhances the expression of surface adhesion molecules and chemokines that promote effector memory T cell activation and trafficking 24. IFNγ also enhances antigen presentation to effector memory T cells by ECs through the upregulation of MHC Class I and II molecules as well as certain costimulators that selectively act upon memory cells 2528. IFNγ only minimally increases HIF-1α in ECs, mostly after prolonged treatment of 24 h or more, and exerts its largest effects by potentiating the response to IFNα through induction of IRF9 23.

ECs, like other cells, respond to IFNγ through the type II IFN receptor 29. Upon ligand binding, JAK2 is activated by autophosphorylation and, in turn, trans-phosphorylates and activates JAK1. Activated JAKs phosphorylate tyrosine residues in the receptor that promote binding and subsequent JAK-mediated tyrosine phosphorylation of STAT1. Phosphorylated STAT1 dissociates from the receptor, forming homodimers that translocate to the nucleus and bind Gamma interferon-activated sequence (GAS) elements to initiate transcription of IFN-stimulated genes (ISGs) 29. Although IFNα acts through a different receptor, utilizes Tyk2 instead of JAK2, and principally activates ISGF3, it also may activate STAT1 homodimers, especially in ECs which display only limited expression of the SHP-2 tyrosine phosphatase that normally limits STAT1 signaling 30. Here we report that IFNγ (and to a lesser extent IFNα) induces the transcription of PHD3 in human ECs. This response depends on STAT1 and is independent of IRF9. Interestingly, IFNγ-mediated induction of PHD3 is selectively observed in ECs, is independent of HIF-1, and may contribute to the immunomodulatory actions of IFNγ on this cell type.

Methods

Cell culture

Human cells were isolated from discarded anonymized tissues or from anonymized adult volunteer blood donors according to protocols approved by the Yale Human Investigation Committee. HUVECs, human dermal microvascular endothelial cells (HDMECs), human aortic smooth muscle cells (HASMCs), human umbilical artery smooth muscle cells (HUASMC), human placental pericytes, and peripheral blood CD4+ T cells were isolated and cultured as previously described 22.

Cytokines, reagents, and antibodies

Sources of cytokines, reagents and antibodies used in this study are listed in the Supplemental Methods at www.ahajournals.org.

Real-time quantitative RT-PCR

RNA was isolated from cells and mRNA was measured by real-time quantitative (qRT-PCR) of 5ul of cDNA template using primers listed in supplemental Table I as described in supplemental methods.

siRNA delivery to cells

All siRNAs were from Qiagen and transfected via electroporation or Oligofectamine (Invitrogen) as described in supplemental methods.

Chromatin immunoprecipitation (ChIP) analysis

ChIP analysis was performed on IFNγ– or vehicle control-treated HUVECs as described in supplemental methods.

Induction of Hypoxia

HUVECs were plated on fibronectin (10 ug/ml)-coated glass plates and exposed to hypoxic conditions (<0.5% O2) in a ProOxC nitrogen-induced hypoxia system (BioSpherix, Red Field, NY) for 6 hours before isolation of protein.

Immunoblotting

Protein lysates were subjected to SDS-PAGE and immunoblotted as previously described 22 and presented in supplemental methods.

Statistical Analysis

Data are presented as mean +/− SE from a minimum of three replicates. Statistical analysis was performed using ANOVA for single and repeated measures with the Bonferroni or Dunnett post-hoc test for comparisons of groups greater than two. Paired t tests were used when appropriate.

Results

IFNγ induces PHD3 in ECs

We recently reported that IFNα can induce transcription of HIF-1α in cultured HUVECs 22. In the present study, we initially examined whether inflammatory cytokines known to act on ECs could alter expression of HIF-regulatory PHD molecules in HUVECs. Cells were treated with IL-1α (2 ng/ml), TNF (10 ng/ml), IFNα (100 ng/ml), or IFNγ (50 ng/ml) for 1.5 hours, and mRNA levels of PHD1, PHD2 and PHD3 were determined by qRT-PCR. These concentrations are optimal to induce new cytokine-dependent gene expression in HUVECs (Fig 1a). PHD3 mRNA was the least abundant prolyl hydroxylase at basal conditions (data not shown). None of these treatments altered the expression of PHD1 or PHD2 after 1.5 or 8 hours of cytokine treatment (Fig 1a and data not shown). IFNγ and, to a lesser extent, IFNα consistently induced PHD3 mRNA at 1.5 hours. Examination of mRNA levels at 8 hours showed continued IFNγ responses but the IFNα effect was not sustained (data not shown). Interestingly, at the 1.5 hour timepoint IFNα and IFNγ stimulated the expression of PHD3 mRNA to a higher level than DFO, a potent inducer of PHD3 mediated via HIF-1 (Fig 1a), although DFO induced higher levels of PHD3 mRNA than IFNγ̣treatment at 8 hours (Fig 1a). We focused our subsequent studies on the IFNγ response.

Figure 1
PHD3 is induced by IFNγ in human ECs

We next examined whether IFNγ could induce PHD3 mRNA expression in other primary human cell types. All cells tested were responsive to IFNγ as indicated by IRF1 mRNA induction (Fig 1b). Although the basal levels of PHD3 mRNA differed among cell types, IFNγ treatment for 1.5 hours (Fig 1b) stimulated the expression of PHD3 mRNA to a small extent in HASMCs, and much more so in HDMECs and HUVECs. IFNγ treatment failed to induce PHD3 mRNA in human peripheral blood CD4+ T cells, human placental-derived pericytes, and HUASMCs. Additionally, IFNγ failed to significantly induce PHD1 and PHD2 mRNA in all cell type tested (data not shown). Thus the induction of PHD3 by IFNγ appears selective for ECs.

IFNγ induced PHD3 mRNA in a dose- (Fig 2a) and time- (Fig 2b) dependent manner. IFNγ stimulated a rapid increase in PHD3 mRNA levels (between 1 & 2 hrs) that slowly decreased over time. Although PHD3 transcripts may exist in alternatively spliced forms 31, 32, the primers used selectively identify the full length active transcript and this was confirmed by sequencing the PCR product amplified from IFNγ-treated HUVECs. We also detected an increase in the levels of a PHD3 protein of the expected size for the product of the full length transcript by immunoblotting as early as 2 hr of IFNγ treatment, and these levels remained constant throughout the time course (Fig 2c). Protein isolated from HUVECs exposed to 6 hrs of hypoxia served as a positive control for PHD3 induction. The effects of IFNγ on protein levels appeared smaller than that observed in response to hypoxia but was highly reproducible.

Figure 2
Dose and time course of IFNγ-induced PHD3

IFNγ-induced PHD3 is an immediate early gene

We next investigated the mechanism by which IFNγ induces the expression of PHD3 in ECs. Pretreatment of HUVECs with the transcription inhibitor DRB (50 uM) blocked the induction of PHD3 mRNA (Fig 3a) and protein (Fig 3b) following IFNγ treatment indicating a requirement for transcription. Additionally, the stability of PHD3 mRNA was examined and found to be unchanged in cells treated with vehicle control or IFNγ for 2 hours followed by the addition of DRB (data not shown). Treatment with the protein synthesis inhibitor CHX (10 ug/ml) did not alter the PHD3 mRNA levels following IFNγ stimulation (Fig 3b). These data suggest that the induction of PHD3 mRNA by IFNγ is dependent on transcription but does not require new protein synthesis, fitting the definition of an immediate early response gene.

Figure 3
Analysis of PHD3 mRNA induction following IFNγ stimulation

IFNγ-induced PHD3 is dependent on JAK/STAT signaling and STAT1

IFNγ transcribes immediate early genes predominately through a JAK/STAT1 signaling pathway. To determine the role of JAK/STAT signaling on PHD3 induction, cells were pretreated with different doses of JAK inhibitor 1, a pharmacologic inhibitor of JAK enzymes, followed by the addition of IFNγ or vehicle control. As a positive control, two known immediate early IFNγ-induced genes, IP-10 and IRF1, were suppressed following treatment with this inhibitor (data not shown). Figure 4a illustrates that JAK inhibitor 1 reduced IFNγ-induced PHD3 mRNA expression in a dose-dependent manner supporting a role for JAK signaling on PHD3 induction.

Figure 4
IFNγ-induced PHD3 is dependent on JAK signaling and STAT1

The transcription factor involved in immediate early responses to IFNγ signaling is typically a STAT1 homodimer. We examined whether IFNγ-induced PHD3 was dependent on STAT1. siRNA against STAT1 was effective in reducing STAT1 protein as assayed by immunoblotting (Fig 4b) and inhibited the expression of IRF1 mRNA (data not shown), as well as induction of PHD3 following IFNγ stimulation (Fig 4c).

To determine whether STAT1 directly regulates the transcription of PHD3, we identified four putative STAT1-binding sites within the 9.0 kb 5’ promoter region of the PHD3 (Fig 4d, top) and then examined whether STAT1 was bound to these sequences in HUVECs treated with IFNγ or vehicle control using ChIP. Figure 4d shows that the DNA sequences −760 and −4678 (relative to the transcriptional start site) bound STAT1 following IFNγ treatment but not in untreated cells. Putative STAT1 sites at positions −076 and −5840 failed to demonstrate STAT1 binding following either IFNγ and vehicle control treatment.

Type I IFNs (IFNα/γ) signal predominately through the ISGF3 complex that is comprised of IRF9, STAT1 and STAT2 and binds to interferon-stimulated response elements (ISREs) 29. Our laboratory has previously reported that IFNα can transiently induce the formation of STAT1 homodimers in HUVECs but not Hela cells, likely due to lesser expression of SHP-2 in ECs 30. To evaluate if the weak and transient response of PHD3 in HUVECs in response to IFNα (Fig 1a) is mediated by a STAT1 homodimer, we used siRNA against IRF9 or STAT1 to inhibit the formation of ISGF3 and evaluated PHD3 mRNA levels following IFNα or IFNγ treatment. siRNA knockdown of IRF9 resulted in a 75% reduction of IRF9 mRNA (Fig Ia for supplemental figures see www.ahajournals.org) and inhibited the induction of an ISGF3-dependent gene, viperin (Fig Ib), but had no effect on the STAT1 homodimer driven gene, IRF1 (Fig Ic) or the induction of PHD3 in either IFNγ– or IFNα-treated ECs (Fig Id). Knockdown of STAT1 abrogated the induction of PHD3 in IFNα-treated ECs (data not shown). These data indicate that both IFNγ and IFNα can induce PHD3 via a STAT1 homodimer-dependent mechanism.

IFNγ-induced PHD3 does not require HIF-1 nor affects its stability during normoxia and hypoxia

PHD3 transcription may be induced by HIF-1, serving as a negative regulator of HIF-1α during periods of hypoxia 6, 11, 33. We therefore explored the possibility that HIF-1 was a transcription factor that could contribute to the induction of PHD3 by IFNγ. Our previous data had demonstrated that IFNγ failed to induce HIF-1α at early timepoints, but was effective in increasing HIF-1α protein levels at later periods 22. Since PHD3 is strongly induced as early as 1.5 hours following IFNγ treatment it seemed unlikely that HIF-1α plays a role in the IFN response. Nevertheless, a siRNA approach was used to determine if knock down of HIF-1α protein altered the ability of IFNγ to induce PHD3. siRNA knock down of HIF-1α was consistently over 90% effective (Fig 5a), and suppressed hypoxia-induced HIF-1α protein (Fig 5b) resulting in the abrogation of PHD3 protein induction during periods of hypoxia (Fig 5c). However, HIF-1α knock down had no effect on IFNγ-mediated induction of PHD3 (Fig 5d). Similarly siRNA knock down of HIF-1β strongly inhibited induction of HIF-1-dependent genes under hypoxic conditions, but had no effect on IFNγ mediated induction of PHD3 during normoxia (Fig II).

Figure 5
IFNγ induces PHD3 independently of HIF-1α

PHD3 may promote the rapid degradation of hypoxia-induced HIF-1α during reoxygenation. We therefore tested if IFNγ treatment during hypoxia would result in an increase of PHD3 when compared to hypoxia alone and if such an increase of PHD3 would accelerate HIF-1α protein decay during reoxygenation. ECs were pretreated with IFNγ or vehicle control then subjected to hypoxia/reoxygenation. IFNγ treatment + hypoxia did significantly increase the levels of PHD3 when compared to vehicle control + hypoxia (Fig IIIa), but did not alter the rate of HIF-1α protein decay during reoxygenation (Fig IIIb). Additionally, IFNγ-induced PHD3 does not alter the basal level of HIF-1α protein during normoxia at early timepoints following IFNγ stimulation (Fig IIIc). These data do not support a role for IFNγ-induced PHD3 in regulating the levels of HIF-1α possibly due to the activities of other PHD isoforms.

DMOG, an inhibitor of PHD activity, suppresses the induction of IFNγ-dependent genes

Since PHD3 levels increase rapidly after IFNγ treatment, we examined whether IFNγ-induced PHD3 may affect IFNγ signaling and subsequent induction of IFNγ-dependent genes. ECs were treated with 1 mM DMOG, a 2-oxoglutarate analog inhibitor that inhibits PHD activity, for 2 hours followed by stimulation with IFNγ or vehicle control for 2 hours, and mRNA levels of 6 known IFNγ-stimulated genes were determined (Treatment with DMOG for periods over 12 hours was toxic for HUVECs, but cells appeared viable under conditions used in this study). Table 1 demonstrates that DMOG treatment significantly suppressed all of the IFNγ-inducible genes examined following IFNγ stimulation. DMOG had minimal effects on the basal levels of these genes with only IRF1 and TAP1 demonstrating small but statistically significant decreases. HUVECs treated with 250 uM DFO, an iron chelator which also inactivates PHDs, for 4 hours followed by IFNγ treatment or vehicle control for 2 hours, yielded similar results as DMOG treatment (Table II). Our results suggest that PHD hydroxylase activity, likely from IFNγ-induced PHD3, contributes to optimal stimulation of IFNγ-dependent genes and thus to the immunomodulatory effect of this cytokine on ECs.

Table 1
DMOG treatment inhibits IFNγ-inducible genes

Discussion

Our data demonstrate that IFNγ can induce PHD3 and this effect is at least partly selective for human ECs. PHD3 behaves as an immediate early response gene and IFNγ-induced transcription is activated by JAK/STAT1 signaling and not HIF. In an attempt to determine the function of this induction, two separate PHD inhibitors, DMOG and DFO were both shown to suppress the induction of IFNγ-dependent genes in ECs consistent with the conclusion that PHD3 contributes to IFNγ signaling. In addition to the pharmacologic inhibitors of PHDs, we treated ECs with IFNγ or vehicle control and subjected them to hypoxia (0.5% O2), which also inactivates PHD activity, in an attempt to assess what role this may have on IFNγ gene transcription. Hypoxic treatment of ECs did inhibit the expression of IFNγ-dependent genes, but it also inhibited gene expression in response to other cytokines that do not induce PHDs (unpublished observations, S.G.). We have placed more emphasis on DMOG and DFO effects which are more likely linked to PHD inhibition as opposed to the global inhibitory effects we have observed with hypoxia.

While DMOG inhibits the hydroxylase activity of all PHDs, it could have PHD-independent effects. To confirm whether the suppression of IFNγ signaling was a result of inhibiting IFNγ-induced PHD3, we attempted to knockdown PHD3 using siRNA. Unfortunately, we were unable to significantly reduce the levels of PHD3 mRNA and protein in HUVEC even though 5 separate previously validated siRNA sequences and 2 different means of siRNA delivery were attempted (unpublished observations, S.G.). The reason for this technical failure is unclear. It is also unclear how prolyl hydroxylation may effect IFNγ-dependent gene transcription. PHD3 can be localized to both cytoplasm and nucleus and has been shown to bind and form complexes with other proteins 6, 34 and thereby stabilize (or destabilize) factors, such as co-activators, that may enhance IFNγ gene transcription. A related aspargynyl hydroxylase, factor inhibiting HIF-1 (FIH), functions to modulate recruitment of coactivators p300 and CBP to HIF-1 6. Further experiments are warranted to decipher the exact role PHD3 plays in IFNγ signaling.

Two splice variants exist for PHD3, one of which lacks the majority of exon 1 (PHD3Δ1), and the other is missing exon 4 (PHD3Δ4). PHD3Δ1 has been shown to lack hydroxylase activity while PHD3Δ4 retains activity 31, 32. PHD3Δ4 has only been described in malignant tissues. The PHD3Δ1 variant can be found in all tissues where wild-type PHD3 is also located. We were able to isolate both full-length PHD3 and PHD3Δ1 from HUVECs treated with IFNγ using DNA primers designed to detect all variants (unpublished observations, S.G.). DNA sequencing confirmed these results. Interestingly, hypoxia also induced both forms of PHD3 in ECs. We do not know what role, if any, PHD3Δ1 plays during hypoxia or IFNγ stimulation.

In summary, we report here a further example of an interaction between immune and hypoxic responses, namely that IFNγ is capable of inducing transcription of PHD3 in human ECs. A physiological role for this phenomenon is suggested by the ability of PHD inhibitors to blunt the response to IFNγ.

Supplementary Material

Acknowledgements

We thank Dr. Deepak Rao for providing T cells, and Dr. George Tellides for providing aortic SMCs. We thank Ms. Louise Benson, Gwen Davis-Arrington, and Lisa Gras for help with endothelial cell isolation and culture.

Sources of Funding: This work was supported by grants from the National Institutes of Health (RO1-HL62188 (JP), T32-AR07107 (SG), T32-A1071001930 (SG) and an Anna Fuller Fund Fellowship (SG)). TJS and LWW were supported by student fellowships from Trinity Hall, Cambridge University.

Footnotes

Disclosure: The authors have nothing to disclose.

References

1. Manalo DJ, Rowan A, Lavoie T, Natarajan L, Kelly BD, Ye SQ, Garcia JG, Semenza GL. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood. 2005;105:659–669. [PubMed]
2. Semenza GL. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol. 1999;15:551–578. [PubMed]
3. Wenger RH, Kvietikova I, Rolfs A, Gassmann M, Marti HH. Hypoxia-inducible factor-1 alpha is regulated at the post-mRNA level. Kidney Int. 1997;51:560–563. [PubMed]
4. Berra E, Ginouves A, Pouyssegur J. The hypoxia-inducible-factor hydroxylases bring fresh air into hypoxia signalling. EMBO Rep. 2006;7:41–45. [PMC free article] [PubMed]
5. Bracken CP, Whitelaw ML, Peet DJ. The hypoxia-inducible factors: key transcriptional regulators of hypoxic responses. Cell Mol Life Sci. 2003;60:1376–1393. [PubMed]
6. Kaelin WG. Proline hydroxylation and gene expression. Annu Rev Biochem. 2005;74:115–128. [PubMed]
7. Masson N, Ratcliffe PJ. HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels. J Cell Sci. 2003;116:3041–3049. [PubMed]
8. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999;399:271–275. [PubMed]
9. Nilsson I, Shibuya M, Wennstrom S. Differential activation of vascular genes by hypoxia in primary endothelial cells. Exp Cell Res. 2004;299:476–485. [PubMed]
10. Pescador N, Cuevas Y, Naranjo S, Alcaide M, Villar D, Landazuri MO, Del Peso L. Identification of a functional hypoxia-responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene. Biochem J. 2005;390:189–197. [PMC free article] [PubMed]
11. Appelhoff RJ, Tian YM, Raval RR, Turley H, Harris AL, Pugh CW, Ratcliffe PJ, Gleadle JM. Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J Biol Chem. 2004;279:38458–38465. [PubMed]
12. Marxsen JH, Stengel P, Doege K, Heikkinen P, Jokilehto T, Wagner T, Jelkmann W, Jaakkola P, Metzen E. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases. Biochem J. 2004;381:761–767. [PMC free article] [PubMed]
13. Cummins EP, Berra E, Comerford KM, Ginouves A, Fitzgerald KT, Seeballuck F, Godson C, Nielsen JE, Moynagh P, Pouyssegur J, Taylor CT. Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proc Natl Acad Sci U S A. 2006;103:18154–18159. [PMC free article] [PubMed]
14. Bishop T, Gallagher D, Pascual A, Lygate CA, de Bono JP, Nicholls LG, Ortega-Saenz P, Oster H, Wijeyekoon B, Sutherland AI, Grosfeld A, Aragones J, Schneider M, van Geyte K, Teixeira D, Diez-Juan A, Lopez-Barneo J, Channon KM, Maxwell PH, Pugh CW, Davies AM, Carmeliet P, Ratcliffe PJ. Abnormal sympathoadrenal development and systemic hypotension in PHD3−/− mice. Mol Cell Biol. 2008;28:3386–3400. [PMC free article] [PubMed]
15. Lipscomb EA, Sarmiere PD, Freemann RS. SM-20 is a novel mitochondrial protein that causes caspase-dependent cell death in nerve growth factor-dependent neurons. Journal of Biological Chemistry. 2001;276:5085–5092. [PubMed]
16. Lee S, Nakamura E, Yang HF, Wei WY, Linggi MS, Sajan MP, Farese RV, Freeman RS, Carter BD, Kaelin WG, Schlisio S. Neuronal apoptosis linked to EgIN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer. Cancer Cell. 2005;8:155–167. [PubMed]
17. Koditz J, Nesper J, Wottawa M, Stiehl DP, Camenisch G, Franke C, Myllyharju J, Wenger RH, Katschinski DM. Oxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensor. Blood. 2007;110:3610–3617. [PubMed]
18. Rantanen K, Pursiheimo J, Hogel H, Himanen V, Metzen E, Jaakkola PM. Prolyl hydroxylase PHD3 activates oxygen-dependent protein aggregation. Mol Biol Cell. 2008;19:2231–2240. [PMC free article] [PubMed]
19. Haddad JJ, Harb HL. Cytokines and the regulation of hypoxia-inducible factor (HIF)-1alpha. Int Immunopharmacol. 2005;5:461–483. [PubMed]
20. McMahon S, Charbonneau M, Grandmont S, Richard DE, Dubois CM. Transforming growth factor beta1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression. J Biol Chem. 2006;281:24171–24181. [PubMed]
21. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V, Johnson RS, Haddad GG, Karin M. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature. 2008;453:807–811. [PMC free article] [PubMed]
22. Gerber SA, Pober JS. IFN-alpha induces transcription of hypoxia-inducible factor-1alpha to inhibit proliferation of human endothelial cells. J Immunol. 2008;181:1052–1062. [PMC free article] [PubMed]
23. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 2004;75:163–189. [PubMed]
24. Harvey EJ, Ramji DP. Interferon-gamma and atherosclerosis: pro- or anti-atherogenic? Cardiovasc Res. 2005;67:11–20. [PubMed]
25. Epperson DE, Arnold D, Spies T, Cresswell P, Pober JS, Johnson DR. Cytokines increase transporter in antigen processing-1 expression more rapidly than HLA class I expression in endothelial cells. J Immunol. 1992;149:3297–3301. [PubMed]
26. Karmann K, Hughes CC, Schechner J, Fanslow WC, Pober JS. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci U S A. 1995;92:4342–4346. [PMC free article] [PubMed]
27. Pober JS. Immunobiology of human vascular endothelium. Immunol Res. 1999;19:225–232. [PubMed]
28. Pober JS, Gimbrone MA, Jr, Cotran RS, Reiss CS, Burakoff SJ, Fiers W, Ault KA. Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon. J Exp Med. 1983;157:1339–1353. [PMC free article] [PubMed]
29. Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol. 2005;5:375–386. [PubMed]
30. Min W, Pober JS, Johnson DR. Interferon induction of TAP1: the phosphatase SHP-1 regulates crossover between the IFN-alpha/beta and the IFN-gamma signal-transduction pathways. Circ Res. 1998;83:815–823. [PubMed]
31. Cervera AM, Apostolova N, Luna-Crespo F, Sanjuan-Pla A, Garcia-Bou R, McCreath KJ. An alternatively spliced transcript of the PHD3 gene retains prolyl hydroxylase activity. Cancer Lett. 2006;233:131–138. [PubMed]
32. Hirsila M, Koivunen P, Gunzler V, Kivirikko KI, Myllyharju J. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J Biol Chem. 2003;278:30772–30780. [PubMed]
33. Stiehl DP, Wirthner R, Koditz J, Spielmann P, Camenisch G, Wenger RH. Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels. Evidence for an autoregulatory oxygen-sensing system. J Biol Chem. 2006;281:23482–23491. [PubMed]
34. Fong GH, Takeda K. Role and regulation of prolyl hydroxylase domain proteins. Cell Death Differ. 2008;15:635–641. [PubMed]

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...